Abstract
Psoriasis clinical trials have measured challenges in assessing disease severity and prognosis. Clinical trials require more objectively validated tools. To determine the severity of the skin disease, measurement systems should be objective, reproducible, easy to apply and practically useful. To maintain the objectivity of observations, different scoring systems have been developed. Scoring systems are essential to monitor the treatment response and evaluate the effectiveness of new drugs. The article reviews different scoring systems for assessing psoriasis and its strengths and weaknesses, as scores are useful for semi-objective assessment. A comprehensive literature search was performed using books, journals and websites. In this article, different scoring systems and their strengths and weaknesses have been summarized.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call